Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 34: 1046-1051, 1988;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hermann, K.
Right arrow Articles by Lang, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hermann, K.
Right arrow Articles by Lang, R. E.

Clinical Chemistry, Vol 34, 1046-1051, Copyright © 1988 by American Association for Clinical Chemistry

Measurement and characterization of angiotensin peptides in plasma

K Hermann, D Ganten, T Unger, C Bayer and RE Lang
Department of Pharmacology, University of Heidelberg, F.R.G.

We report a method for the extraction of angiotensin peptides from plasma with a mixture of acetone, 1 mol/L HCl, and water (40/1/5 by vol). The method is highly reproducible for the measurement of angiotensin I and angiotensin II in small sample volumes, with analytical recoveries of about 80% for both peptides. We investigated the influence of sample handling and found a standard procedure for blood collection, plasma preparation, and extraction was essential. The method was used to measure angiotensin I and II in rat and human plasma. In rat plasma, the mean (+/- SEM) concentrations of angiotensin I and angiotensin II were determined to be 67 (+/- 8) and 14 (+/- 1) pmol/L (n = 10), respectively. Neither angiotensin I nor angiotensin II was detectable 24 h after bilateral nephrectomy. Acute oral administration of the converting-enzyme inhibitor ramipril caused a significant increase of angiotensin I from 85 (+/- 6) to 257 (+/- 33) pmol/L (n = 10; P less than 0.001) and a significant decrease of angiotensin II from 12 (+/- 1) to 7 (+/- 0.4) pmol/L in rat plasma (n = 9; P less than 0.001). In human plasma, angiotensin I and angiotensin II values of 21 (+/- 1) and 6.6 (+/- 0.5) pmol/L (n = 10) were found. A single oral dose of the diuretic furosemide increased angiotensin I significantly from 21 (+/- 1) to 32 (+/- 1.7) pmol/L (n = 5); P less than 0.001), whereas angiotensin II remained unchanged, 6.6 (+/- 0.5) vs 6.4 (+/- 0.4) pmol/L (n = 5). Extracted peptides could be identified as [IIe5]-angiotensin I and [IIe5]-angiotensin II by HPLC in combination with specific radioimmunoassays for angiotensin I and angiotensin II.


The following articles in journals at HighWire Press have cited this article:


Home page
 Hum ReprodHome page
O. A. O'Mahony, O. Djahanbahkch, T. Mahmood, J.R. Puddefoot, and G.P. Vinson
Angiotensin II in human seminal fluid
Hum. Reprod., June 1, 2000; 15(6): 1345 - 1349.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Rauch and H. A. Schmid
Functional evidence for subfornical organ-intrinsic conversion of angiotensin I to angiotensin II
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1630 - R1638.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H.-S. Kim, N. Maeda, G. T. Oh, L. G. Fernandez, R. A. Gomez, and O. Smithies
Homeostasis in Mice with Genetically Decreased Angiotensinogen Is Primarily by an Increased Number of Renin-producing Cells
J. Biol. Chem., May 14, 1999; 274(20): 14210 - 14217.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Schinke, O. Baltatu, M. Bohm, J. Peters, W. Rascher, G. Bricca, A. Lippoldt, D. Ganten, and M. Bader
Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen
PNAS, March 30, 1999; 96(7): 3975 - 3980.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. F. Clark, M. G. F. Sharp, S. D. Morley, S. Fleming, J. Peters, and J. J. Mullins
Renin-1 Is Essential for Normal Renal Juxtaglomerular Cell Granulation and Macula Densa Morphology
J. Biol. Chem., July 18, 1997; 272(29): 18185 - 18190.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. G.F. Sharp, D. Fettes, G. Brooker, A. F. Clark, J. Peters, S. Fleming, and J. J. Mullins
Targeted Inactivation of the Ren-2 Gene in Mice
Hypertension, December 1, 1996; 28(6): 1126 - 1131.
[Abstract] [Full Text]

Home page
 HypertensionHome page
D. J. Campbell, P. Rong, A. Kladis, B. Rees, D. Ganten, and S. L. Skinner
Angiotensin and Bradykinin Peptides in the TGR(mRen-2)27 Rat
Hypertension, May 1, 1995; 25(5): 1014 - 1020.
[Abstract] [Full Text]

Home page
 HypertensionHome page
M. A. Lee, M. Bohm, S. Kim, S. Bachmann, J. Bachmann, M. Bader, and D. Ganten
Differential Gene Expression of Renin and Angiotensinogen in the TGR(mREN-2)27 Transgenic Rat
Hypertension, April 1, 1995; 25(4): 570 - 580.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
S. Kantachuvesiri, S. Fleming, J. Peters, B. Peters, G. Brooker, A. G. Lammie, I. McGrath, Y. Kotelevtsev, and J. J. Mullins
Controlled Hypertension, a Transgenic Toggle Switch Reveals Differential Mechanisms Underlying Vascular Disease
J. Biol. Chem., September 21, 2001; 276(39): 36727 - 36733.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Association for Clinical Chemistry.